NDC Product
Fluzone Trivalent Northern Hemisphere NDC 49281-425
- Generic Name
- N/A
- Dosage Form
- N/A
- Route
- N/A
- Marketing
- BLA
Active Listing
Influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Injectable Suspension
RxNorm 2746456 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Injectable Suspension (RxCUI 2746456). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
